Tag:
Stallergenes
Latest Headlines
Latest Headlines
Allergy biomarkers could track treatment response
Stallergenes has discovered two biomarkers that could help therapists monitor how well a treatment is working, and also act as measuring points in clinical trials.
Stallergenes hunts for U.S. partner
European allergy company Stallergenes is preparing to look for a U.S. partner for its oral hay-fever treatment Oralair. The search will begin in Q4 after the France-based company meets with the FDA.
Merck, Stallergenes race to FDA with new allergy treatments
Merck and Stallergenes are preparing to approach the FDA with two new therapies that promise to replace the traditional allergy shot with sub-lingual treatments that would be a lot easier to take as
